Scientific Advisors
Elena Hawryluk, MD, PhD
Frederick Beddingfield, MD, PhD
Associate Professor of Dermatology at Massachusetts General Hospital.
Frederick Beddingfield, MD, PhD
Frederick Beddingfield, MD, PhD
CEO of Kira Pharmaceuticals
Jeffrey Gershenwald, MD
Jeffrey Gershenwald, MD
Professor of Surgical Oncology and Cancer Biology at the MD Anderson Cancer Center, and Medical Director of the Melanoma and Skin Cancer Center.
Jennifer Wargo, MD
Andrew Futreal, PhD
Jeffrey Gershenwald, MD
Professor of Genomic Medicine and Surgical Oncology at the MD Anderson Cancer Center.
Andrew Futreal, PhD
Andrew Futreal, PhD
Andrew Futreal, PhD
Professor and Chair of the Department of Genomic Medicine at MD Anderson Cancer Center.
Miriam Bredella, MD
Andrew Futreal, PhD
Andrew Futreal, PhD
Special Advisor on Faculty Support and Well-Being, Professor of Radiology, Vice Chair for Faculty Affairs and Director of the Center for Faculty Development at Massachusetts General Hospital.
Susan Swetter, MD
Director of the Pigmented Lesions and Melanoma Program at Stanford Medical School, and the Co-founder and Co-Chair of the national Melanoma Prevention Working Group.
Glenn Merlino, PhD
Scientific Director for Basic Research Center for Cancer Research at the National Cancer Institute (NCI) and Senior Investigator, Laboratory of Cancer Biology & Genetics at NCI.
Maryam Asgari, MD
Maryam Asgari, MD
Professor and Chair of Dermatology at the University of Colorado School of Medicine.
John Doench, PhD
John Doench, PhD
Maryam Asgari, MD
Director of Research and Development for the Genetic Perturbation Program (GPP) and Institute Scientist at the Broad Institute of MIT and Harvard.
Lyn Duncan, MD
John Doench, PhD
Lyn Duncan, MD
Professor of Pathology at Harvard Medical School and former Director of Dermatopathology at Massachusetts General Hospital.
Xu Wu, PhD
John Doench, PhD
Lyn Duncan, MD
Associate Professor of Dermatology at Massachusetts General Hospital.